EPISODE · Mar 20, 2024 · 56 MIN
TechBio Founders #30: Developing drug pipelines for life extension and age-related disorders with Ivan De Weber, CEO at Cortex Discovery
from Next Sequence · host Ivan De Weber, Loretta TIOIELA
Cortex Discovery’s in silico drug discovery platform is based on its leading-edge AI technology which can predict molecule properties in all therapeutic fields. The accuracy of its predictions has been validated in the lab, and rivals that of experiments.
Embed this episode
NOW PLAYING
TechBio Founders #30: Developing drug pipelines for life extension and age-related disorders with Ivan De Weber, CEO at Cortex Discovery
No transcript for this episode yet
Similar Episodes
No similar episodes found.